{"info": {"address1": "777 Old Saw Mill River Road", "city": "Tarrytown", "state": "NY", "zip": "10591-6707", "country": "United States", "phone": "914 847 7000", "website": "https://www.regeneron.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.", "fullTimeEmployees": 11851, "companyOfficers": [{"maxAge": 1, "name": "Dr. Leonard S. Schleifer M.D., Ph.D.", "age": 69, "title": "Co-Founder, Pres, CEO & Director", "yearBorn": 1953, "fiscalYear": 2021, "totalPay": 6470514, "exercisedValue": 446385152, "unexercisedValue": 166813520}, {"maxAge": 1, "name": "Dr. George D. Yancopoulos M.D., Ph.D.", "age": 62, "title": "Co-Founder, Pres, Chief Scientific Officer & Director", "yearBorn": 1960, "fiscalYear": 2021, "totalPay": 6398364, "exercisedValue": 172024752, "unexercisedValue": 157781072}, {"maxAge": 1, "name": "Mr. Robert E. Landry Jr.", "age": 58, "title": "Exec. VP of Fin. & CFO", "yearBorn": 1964, "fiscalYear": 2021, "totalPay": 1899182, "exercisedValue": 3481150, "unexercisedValue": 22529406}, {"maxAge": 1, "name": "Mr. Joseph J. LaRosa", "age": 63, "title": "Exec. VP, Gen. Counsel & Sec.", "yearBorn": 1959, "fiscalYear": 2021, "totalPay": 1748110, "exercisedValue": 23227300, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew J. Murphy Ph.D.", "age": 63, "title": "Exec. VP of Research", "yearBorn": 1959, "fiscalYear": 2021, "totalPay": 1568110, "exercisedValue": 19756644, "unexercisedValue": 74316984}, {"maxAge": 1, "name": "Mr. Daniel P. Van Plew", "age": 49, "title": "Exec. VP and GM of Industrial Operations & Product Supply", "yearBorn": 1973, "fiscalYear": 2021, "totalPay": 1774337, "exercisedValue": 17958000, "unexercisedValue": 45967372}, {"maxAge": 1, "name": "Ms. Patrice  Gilooly", "title": "Sr. VP of Quality Assurance & Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher R. Fenimore", "age": 51, "title": "Sr. VP, Head of Accounting & Controller", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerald  Underwood", "title": "Sr. VP of Technical Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bob  McCowan", "title": "Sr. VP of IT & Chief Information Officer", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1680307200, "compensationAsOfEpochDate": 1640908800, "maxAge": 86400, "priceHint": 2, "previousClose": 819.74, "open": 822.17, "dayLow": 804.1528, "dayHigh": 823.375, "regularMarketPreviousClose": 819.74, "regularMarketOpen": 822.17, "regularMarketDayLow": 804.1528, "regularMarketDayHigh": 823.375, "payoutRatio": 0.0, "beta": 0.226643, "trailingPE": 21.179815, "forwardPE": 17.95179, "volume": 499761, "regularMarketVolume": 499761, "averageVolume": 610852, "averageVolume10days": 437060, "averageDailyVolume10Day": 437060, "bid": 0.0, "ask": 0.0, "bidSize": 1100, "askSize": 800, "marketCap": 88336498688, "fiftyTwoWeekLow": 538.01, "fiftyTwoWeekHigh": 837.55, "priceToSalesTrailing12Months": 7.256816, "fiftyDayAverage": 780.3892, "twoHundredDayAverage": 712.90436, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 83469787136, "profitMargins": 0.35639998, "floatShares": 102128863, "sharesOutstanding": 107507000, "sharesShort": 1300556, "sharesShortPriorMonth": 1197786, "sharesShortPreviousMonthDate": 1677542400, "dateShortInterest": 1680220800, "sharesPercentSharesOut": 0.0119, "heldPercentInsiders": 0.02563, "heldPercentInstitutions": 0.89825994, "shortRatio": 1.92, "shortPercentOfFloat": 0.0126, "impliedSharesOutstanding": 0, "bookValue": 211.813, "priceToBook": 3.8147328, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": -0.463, "netIncomeToCommon": 4338400256, "trailingEps": 38.15, "forwardEps": 45.01, "pegRatio": 7.08, "enterpriseToRevenue": 6.857, "enterpriseToEbitda": 15.645, "52WeekChange": 0.12282872, "SandP52WeekChange": -0.06829989, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "REGN", "underlyingSymbol": "REGN", "shortName": "Regeneron Pharmaceuticals, Inc.", "longName": "Regeneron Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 670602600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e55aa808-7510-354a-9528-01782e66194d", "messageBoardId": "finmb_33715", "gmtOffSetMilliseconds": -14400000, "currentPrice": 808.01, "targetHighPrice": 1040.0, "targetLowPrice": 650.0, "targetMeanPrice": 878.3, "targetMedianPrice": 880.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 23, "totalCash": 7742300160, "totalCashPerShare": 72.544, "ebitda": 5335399936, "totalDebt": 2701400064, "quickRatio": 4.161, "currentRatio": 5.057, "totalRevenue": 12172900352, "debtToEquity": 11.919, "revenuePerShare": 113.659, "returnOnAssets": 0.11423001, "returnOnEquity": 0.20942, "grossProfits": 7020000000, "freeCashflow": 2640525056, "operatingCashflow": 5014900224, "earningsGrowth": -0.467, "revenueGrowth": -0.31, "grossMargins": 0.57668996, "ebitdaMargins": 0.4383, "operatingMargins": 0.41026002, "financialCurrency": "USD", "trailingPegRatio": 3.525}, "news": [{"uuid": "9ecad592-a908-336d-b44a-fa220c886707", "title": "Regeneron Pharmaceuticals' (NASDAQ:REGN) investors will be pleased with their splendid 159% return over the last five years", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-nasdaq-regn-investors-140018254.html", "providerPublishTime": 1681826418, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "55a011b5-f2e6-37f4-a386-d6d83b60c701", "title": "Regeneron Set to Reach New Heights: $1,000 in Sight?", "publisher": "TheStreet.com", "link": "https://finance.yahoo.com/m/55a011b5-f2e6-37f4-a386-d6d83b60c701/regeneron-set-to-reach-new.html", "providerPublishTime": 1681739400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_Num7gsaLwbu.vZlUMqyZg--~B/aD0xMDY3O3c9MTYwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/thestreet.com/72e962eb044693c2eac2019109d906cf", "width": 1600, "height": 1067, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5Jm36_Ph463bCzv0i8uhMg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/thestreet.com/72e962eb044693c2eac2019109d906cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "831e77bb-f12f-32eb-adcf-f83ecb7548e5", "title": "Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/regeneron-announces-retirement-board-chair-113000827.html", "providerPublishTime": 1681731000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBn5GKQBxPWKQ64h5BTqqw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 800, "height": 126, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Z.v1_LzEKhIPoy9U5NlmXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "61210bae-5754-3369-a522-bb2a634251f3", "title": "Aflibercept 8 mg and EYLEA\u00ae (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aflibercept-8-mg-eylea-aflibercept-110000553.html", "providerPublishTime": 1681729200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBn5GKQBxPWKQ64h5BTqqw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 800, "height": 126, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Z.v1_LzEKhIPoy9U5NlmXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "18425e08-d615-3c30-b22b-fc16d5cc6918", "title": "Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals, Inc.'s NASDAQ:REGN) Stock?", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/strong-financial-prospects-force-driving-140040948.html", "providerPublishTime": 1681480840, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "58e680bb-41c5-33a5-a7c6-dc85e5a3d45f", "title": "Regeneron Announces Investor Conference Presentations", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/regeneron-announces-investor-conference-presentations-200000586.html", "providerPublishTime": 1681243200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/OBn5GKQBxPWKQ64h5BTqqw--~B/aD0xMjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 800, "height": 126, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/Z.v1_LzEKhIPoy9U5NlmXQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/2788fcd6c9b4dcf523fc2cc341eb4142", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["REGN"]}, {"uuid": "fc42d06b-0f85-37e8-ab14-c76c261f3646", "title": "12 Best Covid Treatment Stocks to Buy Today", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/12-best-covid-treatment-stocks-145125042.html", "providerPublishTime": 1681224685, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UkIrqpqAAkgb0aMLpfV9uQ--~B/aD00NTA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/b59f475277cb8c4b57fab9a05923d82d", "width": 800, "height": 450, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/xJzPY2pRVOeaUv6DOakP1A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/b59f475277cb8c4b57fab9a05923d82d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AZN", "JNJ", "GSK", "PFE", "BNTX", "MRNA", "REGN", "NVAX", "LLY", "GILD"]}, {"uuid": "faa4b0ae-96fc-3f70-99a9-ce878037a999", "title": "Investing $1,000 In These 2 Top Stocks Would Be a Great Move", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/faa4b0ae-96fc-3f70-99a9-ce878037a999/investing-%241%2C000-in-these-2.html", "providerPublishTime": 1681047000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JtCds4n4ZCC6N61JmW.5Xg--~B/aD0xMjk5O3c9MjMwOTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/828b309e2eafab4053c3b6b035ddc01d", "width": 2309, "height": 1299, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/wNFJfvi9WBMNZMtInIWNPg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/828b309e2eafab4053c3b6b035ddc01d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HCA", "REGN"]}]}